Total Assets (Quarterly) Chart

View Total Assets (Quarterly) for APYX.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Total Assets (Quarterly) Chart
Start Trial

Historical Total Assets (Quarterly) Data

View and export this data back to 1998. Start Trial.
Date Value
June 30, 2026 61.07M
March 31, 2026 63.02M
December 31, 2025 66.84M
September 30, 2025 57.36M
June 30, 2025 58.19M
March 31, 2025 60.16M
December 31, 2024 64.84M
September 30, 2024 60.72M
June 30, 2024 65.39M
March 31, 2024 70.71M
December 31, 2023 79.24M
September 30, 2023 59.45M
June 30, 2023 62.43M
March 31, 2023 56.78M
December 31, 2022 51.78M
September 30, 2022 55.27M
June 30, 2022 59.47M
March 31, 2022 63.00M
December 31, 2021 68.72M
September 30, 2021 67.77M
June 30, 2021 69.60M
March 31, 2021 71.10M
December 31, 2020 74.11M
September 30, 2020 75.42M
June 30, 2020 77.83M
Date Value
March 31, 2020 82.12M
December 31, 2019 84.74M
September 30, 2019 86.94M
June 30, 2019 88.88M
March 31, 2019 91.70M
December 31, 2018 95.76M
September 30, 2018 113.17M
June 30, 2018 30.65M
March 31, 2018 30.11M
December 31, 2017 31.18M
September 30, 2017 30.70M
June 30, 2017 32.56M
March 31, 2017 33.09M
December 31, 2016 35.11M
September 30, 2016 29.15M
June 30, 2016 29.59M
March 31, 2016 29.74M
December 31, 2015 31.45M
September 30, 2015 33.12M
June 30, 2015 34.13M
March 31, 2015 34.59M
December 31, 2014 24.83M
September 30, 2014 31.29M
June 30, 2014 31.60M
March 31, 2014 32.51M

Total Assets Definition

Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.

Read full definition.

Total Assets (Quarterly) Range, Past 5 Years

View Total Assets (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Total Assets (Quarterly) Benchmarks

View Total Assets (Quarterly) Benchmarks
Start Trial
Abbott Laboratories 109.22B
AngioDynamics, Inc. 267.16M
Alphatec Holdings, Inc. 791.03M
AtriCure, Inc. 676.64M
Baxter International, Inc. 19.79B

Total Assets (Quarterly) Related Metrics